Sökning: onr:"swepub:oai:lup.lub.lu.se:08ffa3a1-1300-4948-8c33-d06b58a21bb1" >
Influence of APOA5 ...
Influence of APOA5 locus on the treatment efficacy of three statins : Evidence from a randomized pilot study in Chinese subjects
-
- Hua, Sha (författare)
- Shanghai Jiao Tong University
-
- Ma, Chuanxiang (författare)
- Affiliated Hospital of Weifang Medical University
-
- Zhang, Jun (författare)
- Third Affiliated Hospital of Soochow University
-
visa fler...
-
- Li, Jing (författare)
- Shanghai Jiao Tong University
-
- Wu, Weiwei (författare)
- Shanghai Jiao Tong University
-
- Xu, Ning (författare)
- Lund University,Lunds universitet,Avdelningen för klinisk kemi och farmakologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Chemistry and Pharmacology,Department of Laboratory Medicine,Faculty of Medicine
-
- Luo, Guanghua (författare)
- Third Affiliated Hospital of Soochow University
-
- Zhao, Jianrong (författare)
- Shanghai Jiao Tong University
-
visa färre...
-
(creator_code:org_t)
- 2018-04-11
- 2018
- Engelska.
-
Ingår i: Frontiers in Pharmacology. - : Frontiers Media SA. - 1663-9812. ; 9:APR
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://www.frontier...
-
https://lup.lub.lu.s...
-
https://doi.org/10.3...
-
visa färre...
Abstract
Ämnesord
Stäng
- Pharmacogenetics or pharmacogenomics approaches are important for addressing the individual variabilities of drug efficacy especially in the era of precision medicine. One particular interesting gene to investigate is APOA5, which has been repeatedly linked with the inter-individual variations of serum triglycerides. Here, we explored APOA5-statin interactions in 195 Chinese subjects randomized to rosuvastatin (5-10 mg/day), atorvastatin (10-20 mg/day), or simvastatin (40 mg/day) for 12 weeks by performing a targeted genotyping analysis of the APOA5 promoter SNP rs662799 (-1131T > C). There were no significant differences between the treatment arms for any of the statin-induced changes in clinical biomarkers. Reductions in LDL cholesterol were influenced by the APOA5 genotype in all three treatment groups. By contrast, changes in HDL cholesterol, and triglycerides were only affected by the APOA5 genotype in the atorvastatin and simvastatin groups and not in the rosuvastatin group. Our results suggest that future studies may need to consider stratifying subjects not only by genetic background but also by prescribed statin type.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Nyckelord
- APOA5 genotype
- Dyslipidemia
- LDL cholesterol
- Statins
- Triglycerides
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas